• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. OPTIPAC 40 REFOBACIN BONE CEMENT; BONE CEMENT, ANTIBIOTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. OPTIPAC 40 REFOBACIN BONE CEMENT; BONE CEMENT, ANTIBIOTIC Back to Search Results
Model Number N/A
Device Problems Infusion or Flow Problem (2964); No Flow (2991)
Patient Problems No Consequences Or Impact To Patient (2199); No Information (3190)
Event Date 12/13/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Multiple mdr's were submitted for this event.Please see reports: 3006946279 - 2018 - 00007.Report source- foreign.The event occurred in (b)(6).Pma 510(k): - the product within this report is a combination product.The investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.Not returned to manufacturer.
 
Event Description
It was reported the monomer liquid of two batches of cement would not enter the cannister.A 15 minute delay to surgery was reported as a result.The surgery was completed with another batch.No further information has been made available at this time.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.  the device manufacturing quality record indicates that the released product met all requirements to perform as intended.Complaint sample was evaluated and the reported event was confirmed.The returned device was evaluated and the device cannula was blocked by a plug of cement, which prevented the monomer to flow inside the device cylinder.Investigation results concluded that the reported event was likely due to an handling error.  if any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
 
Event Description
It was been reported that the monomer liquid of the optipac from two different batches would not enter the optipac cylinder.A 15 minute delay to surgery was reported as a result.The surgery was completed with a product from another batch.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIPAC 40 REFOBACIN BONE CEMENT
Type of Device
BONE CEMENT, ANTIBIOTIC
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
MDR Report Key7175036
MDR Text Key96834065
Report Number3006946279-2018-00006
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
PMA/PMN Number
K150850
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Type of Report Initial,Followup,Followup
Report Date 03/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/09/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date06/30/2018
Device Model NumberN/A
Device Catalogue Number4710500394-1
Device Lot NumberA65D05170
Other Device ID Number(01) 03599870112212
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/29/2018
Was the Report Sent to FDA? No
Date Manufacturer Received12/20/2018
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberN/A
Patient Sequence Number1
-
-